Outcomes of patients with solid tumour malignancies treated with first-line immuno-oncology agents who do not meet eligibility criteria for clinical trials

Chun L. Gan; Igor Stukalin; Daniel E. Meyers; Shaan Dudani; Heidi A.I. Grosjean; Samantha Dolter; Benjamin W. Ewanchuk; Siddhartha Goutam; Michael Sander; Connor Wells; Aliyah Pabani; Tina Cheng; Jose Monzon; Don Morris; Naveen S. Basappa; Sumanta K. Pal; Lori A. Wood; Frede Donskov; Toni K. Choueiri; Daniel Y.C. Heng

doi:10.1016/j.ejca.2021.04.004

Outcomes of patients with solid tumour malignancies treated with first-line immuno-oncology agents who do not meet eligibility criteria for clinical trials

Chun L. Gan, Igor Stukalin, Daniel E. Meyers, Shaan Dudani, Heidi A.I. Grosjean, Samantha Dolter, Benjamin W. Ewanchuk, Siddhartha Goutam, Michael Sander, Connor Wells, Aliyah Pabani, Tina Cheng, Jose Monzon, Don Morris, Naveen S. Basappa, Sumanta K. Pal, Lori A. Wood, Frede Donskov, Toni K. Choueiri, Daniel Y.C. Heng

Research output: Contribution to journal › Article › peer-review

28 Citations (Scopus)

Original language	English
Pages (from-to)	115-125
Number of pages	11
Journal	European Journal of Cancer
Volume	151
DOIs	https://doi.org/10.1016/j.ejca.2021.04.004
Publication status	Published - Jul 2021
Externally published	Yes

ASJC Scopus Subject Areas

Oncology
Cancer Research

Keywords

Clinical outcomes
Clinical trial ineligible
IMDC
Immuno-oncology
Immunotherapy
Melanoma
Non–small-cell lung cancer
Real-world patients
Renal cell carcinoma
Trial eligibility

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.ejca.2021.04.004

Cite this

Gan, C. L., Stukalin, I., Meyers, D. E., Dudani, S., Grosjean, H. A. I., Dolter, S., Ewanchuk, B. W., Goutam, S., Sander, M., Wells, C., Pabani, A., Cheng, T., Monzon, J., Morris, D., Basappa, N. S., Pal, S. K., Wood, L. A., Donskov, F., Choueiri, T. K., & Heng, D. Y. C. (2021). Outcomes of patients with solid tumour malignancies treated with first-line immuno-oncology agents who do not meet eligibility criteria for clinical trials. European Journal of Cancer, 151, 115-125. https://doi.org/10.1016/j.ejca.2021.04.004

Gan, CL, Stukalin, I, Meyers, DE, Dudani, S, Grosjean, HAI, Dolter, S, Ewanchuk, BW, Goutam, S, Sander, M, Wells, C, Pabani, A, Cheng, T, Monzon, J, Morris, D, Basappa, NS, Pal, SK, Wood, LA, Donskov, F, Choueiri, TK & Heng, DYC 2021, 'Outcomes of patients with solid tumour malignancies treated with first-line immuno-oncology agents who do not meet eligibility criteria for clinical trials', European Journal of Cancer, vol. 151, pp. 115-125. https://doi.org/10.1016/j.ejca.2021.04.004

@article{28410ab027d94611913af164b68e98be,

title = "Outcomes of patients with solid tumour malignancies treated with first-line immuno-oncology agents who do not meet eligibility criteria for clinical trials",

keywords = "Clinical outcomes, Clinical trial ineligible, IMDC, Immuno-oncology, Immunotherapy, Melanoma, Non–small-cell lung cancer, Real-world patients, Renal cell carcinoma, Trial eligibility",

author = "Gan, {Chun L.} and Igor Stukalin and Meyers, {Daniel E.} and Shaan Dudani and Grosjean, {Heidi A.I.} and Samantha Dolter and Ewanchuk, {Benjamin W.} and Siddhartha Goutam and Michael Sander and Connor Wells and Aliyah Pabani and Tina Cheng and Jose Monzon and Don Morris and Basappa, {Naveen S.} and Pal, {Sumanta K.} and Wood, {Lori A.} and Frede Donskov and Choueiri, {Toni K.} and Heng, {Daniel Y.C.}",

note = "Publisher Copyright: {\textcopyright} 2021 The Authors",

year = "2021",

month = jul,

doi = "10.1016/j.ejca.2021.04.004",

language = "English",

volume = "151",

pages = "115--125",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Elsevier Limited",

}

TY - JOUR

T1 - Outcomes of patients with solid tumour malignancies treated with first-line immuno-oncology agents who do not meet eligibility criteria for clinical trials

AU - Gan, Chun L.

AU - Stukalin, Igor

AU - Meyers, Daniel E.

AU - Dudani, Shaan

AU - Grosjean, Heidi A.I.

AU - Dolter, Samantha

AU - Ewanchuk, Benjamin W.

AU - Goutam, Siddhartha

AU - Sander, Michael

AU - Wells, Connor

AU - Pabani, Aliyah

AU - Cheng, Tina

AU - Monzon, Jose

AU - Morris, Don

AU - Basappa, Naveen S.

AU - Pal, Sumanta K.

AU - Wood, Lori A.

AU - Donskov, Frede

AU - Choueiri, Toni K.

AU - Heng, Daniel Y.C.

PY - 2021/7

Y1 - 2021/7

KW - Clinical outcomes

KW - Clinical trial ineligible

KW - IMDC

KW - Immuno-oncology

KW - Immunotherapy

KW - Melanoma

KW - Non–small-cell lung cancer

KW - Real-world patients

KW - Renal cell carcinoma

KW - Trial eligibility

UR - http://www.scopus.com/inward/record.url?scp=85105516700&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85105516700&partnerID=8YFLogxK

U2 - 10.1016/j.ejca.2021.04.004

DO - 10.1016/j.ejca.2021.04.004

M3 - Article

C2 - 33975059

AN - SCOPUS:85105516700

SN - 0959-8049

VL - 151

SP - 115

EP - 125

JO - European Journal of Cancer

JF - European Journal of Cancer

ER -

Outcomes of patients with solid tumour malignancies treated with first-line immuno-oncology agents who do not meet eligibility criteria for clinical trials

ASJC Scopus Subject Areas

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this